Alan A Musso
CIK 1295830 · Chief Financial Officer · last filed 2026-02-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
4
Total Filings
47
Lifetime Open-Market Net
-$1.45M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| FULC | Chief Financial Officer | — | $3.45 | — | $0 | 5 | 2026-02-04 |
| RNTX | Director | — | $0.96 | — | $0 | 1 | 2025-07-23 |
| Rein Therapeutics, Inc. (ALRN) Delisted | Director | — | $2.11 | — | $0 | 3 | 2024-12-06 |
| BELLICUM PHARMACEUTICALS, INC (BLCM) Delisted | CFO and Treasurer | 26,548 | $0.07 | $2.0K | -$1.45M | 14 | 2018-07-05 |
Recent Filings · Page 5 of 5
47 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-08-11 | — | Mixed | — | -$58.6K | |
| 2009-07-31 | — | Mixed | — | -$50.2K | |
| 2009-07-30 | — | Mixed | — | -$28.2K | |
| 2009-01-13 | — | Grant (A) | — | $0 | |
| 2008-08-19 | — | Mixed | — | -$5.0K | |
| 2008-08-15 | — | Mixed | — | -$77.5K | |
| 2007-12-21 | — | Grant (A) | — | $0 |
Showing 41–47 of 47
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.